Biological preparations for the treatment of hematological and solid tumor cancers using genetically engineered cells; pharmaceutical preparations for targeting tissues based on select tissue markers and ligands for treating hematological and solid tumor cancers; pharmaceutical preparations for the purpose of binding ligands using receptors for treating hematological and solid tumor cancers; pharmaceutical preparations for immunotherapy using genetically engineered cells for treating hematological and solid tumor cancers
Pharmaceuticals